Item Type | Name |
Academic Article
|
Once-daily, extended-release formulations of antimuscarinic agents in the treatment of overactive bladder: a review.
|
Academic Article
|
The overactive bladder: an overview for primary care health providers.
|
Academic Article
|
Definition and epidemiology of overactive bladder.
|
Academic Article
|
Trospium chloride in the management of overactive bladder.
|
Academic Article
|
Tolterodine for the treatment of overactive bladder: a review.
|
Academic Article
|
Nighttime dosing with tolterodine reduces overactive bladder-related nocturnal micturitions in patients with overactive bladder and nocturia.
|
Academic Article
|
Tolterodine and tamsulosin for treatment of men with lower urinary tract symptoms and overactive bladder: a randomized controlled trial.
|
Academic Article
|
Effect of tolterodine extended release with or without tamsulosin on measures of urgency and patient reported outcomes in men with lower urinary tract symptoms.
|
Academic Article
|
Urodynamics in the evaluation of overactive bladder.
|
Academic Article
|
Urodynamic results and clinical outcomes with intradetrusor injections of onabotulinumtoxinA in a randomized, placebo-controlled dose-finding study in idiopathic overactive bladder.
|
Academic Article
|
Evaluation and treatment of the overactive bladder.
|
Academic Article
|
Suppression of human detrusor smooth muscle excitability and contractility via pharmacological activation of large conductance Ca2+-activated K+ channels.
|
Academic Article
|
The management of overactive bladder syndrome.
|
Academic Article
|
SK channel-selective opening by SKA-31 induces hyperpolarization and decreases contractility in human urinary bladder smooth muscle.
|
Academic Article
|
Update on overactive bladder: pharmacologic approaches on the horizon.
|
Academic Article
|
Efficacy and tolerability of tolterodine extended-release in men with overactive bladder and urgency urinary incontinence.
|
Academic Article
|
Trospium chloride: the European experience.
|
Academic Article
|
Tolterodine extended release improves overactive bladder symptoms in men with overactive bladder and nocturia.
|
Academic Article
|
Fesoterodine dose response in subjects with overactive bladder syndrome.
|
Academic Article
|
Tolterodine extended release is efficacious in continent and incontinent subjects with overactive bladder.
|
Academic Article
|
Stress incontinence surgery: which operation when?
|
Academic Article
|
Randomized trial of percutaneous tibial nerve stimulation versus extended-release tolterodine: results from the overactive bladder innovative therapy trial.
|
Academic Article
|
Frequently asked questions in the evaluation and management of overactive bladder.
|
Academic Article
|
Response to fesoterodine in patients with an overactive bladder and urgency urinary incontinence is independent of the urodynamic finding of detrusor overactivity.
|
Academic Article
|
Patient-reported reasons for discontinuing overactive bladder medication.
|
Academic Article
|
Long-term durability of percutaneous tibial nerve stimulation for the treatment of overactive bladder.
|
Academic Article
|
Trospium chloride once-daily extended release is efficacious and tolerated in elderly subjects (aged = 75 years) with overactive bladder syndrome.
|
Academic Article
|
Once-daily trospium chloride 60 mg extended release in subjects with overactive bladder syndrome who use multiple concomitant medications: Post hoc analysis of pooled data from two randomized, placebo-controlled trials.
|
Academic Article
|
Neurogenic detrusor overactivity is associated with decreased expression and function of the large conductance voltage- and Ca(2+)-activated K(+) channels.
|
Concept
|
Urinary Bladder, Overactive
|
Academic Article
|
OnabotulinumtoxinA improves urodynamic outcomes in patients with neurogenic detrusor overactivity.
|
Academic Article
|
Chapter 6: Practical aspects of administration of onabotulinumtoxinA.
|
Academic Article
|
Patient-reported goal achievement following onabotulinumtoxinA treatment in patients with neurogenic detrusor overactivity.
|
Academic Article
|
BK channel regulation by phosphodiesterase type 1: a novel signaling pathway controlling human detrusor smooth muscle function.
|
Academic Article
|
Lower urinary tract symptoms in women: epidemiology, diagnosis, and management.
|
Academic Article
|
Low-dose Desmopressin and Tolterodine Combination Therapy for Treating Nocturia in Women with Overactive Bladder: A Double-blind, Randomized, Controlled Study.
|
Academic Article
|
A Prospective, non-intErventional Registry Study of PatiEnts initiating a Course of drug Therapy for overactIVE bladder (PERSPECTIVE): Rationale, design, and methodology.
|
Academic Article
|
Six-Month Results of Selective Bladder Denervation in Women with Refractory Overactive Bladder.
|
Academic Article
|
Re: Six-Month Results of Selective Bladder Denervation in Women with Refractory Overactive Bladder.
|
Academic Article
|
Feasibility of a Fully Implanted, Nickel Sized and Shaped Tibial Nerve Stimulator for the Treatment of Overactive Bladder Syndrome with Urgency Urinary Incontinence.
|
Academic Article
|
Factors Associated with Improvements in Patient-Reported Outcomes During Mirabegron or Antimuscarinic Treatment of Overactive Bladder Syndrome: A Registry Study (PERSPECTIVE).
|
Academic Article
|
One-year results with selective bladder denervation in women with refractory overactive bladder.
|
Academic Article
|
Evaluating the safety and potential activity of URO-902 (hMaxi-K) gene transfer by intravesical instillation or direct injection into the bladder wall in female participants with idiopathic (non-neurogenic) overactive bladder syndrome and detrusor overactivity from two double-blind, imbalanced, placebo-controlled randomized phase 1 trials.
|
Academic Article
|
Persistence with mirabegron or antimuscarinic treatment for overactive bladder syndrome: Findings from the PERSPECTIVE registry study.
|
Academic Article
|
Gene Therapy for Overactive Bladder: A Review of BK-Channel a-Subunit Gene Transfer.
|
Academic Article
|
Does urinary urgency drive urinary frequency in overactive bladder?
|